Results of a surgical resection of pulmonary metastasis from malignant head and neck tumor
- PMID: 20123888
- DOI: 10.1510/icvts.2009.219766
Results of a surgical resection of pulmonary metastasis from malignant head and neck tumor
Abstract
There have been only a few reports about a surgical resection of pulmonary metastasis from malignant head and neck tumor. Here we investigate the survival after a pulmonary metastasectomy, and discuss the prognostic factors. We retrospectively reviewed 25 patients who underwent a pulmonary metastasectomy from malignant head and neck tumor at Kyushu University Hospital from 1981 through 2008. We assessed the five year overall survival by the Kaplan-Meier method and the log-rank (Mantel-Cox) test using the Stat View software program. The three- or five-year overall survival after a metastasectomy was 53.3% and 50.0%, respectively. We investigated the clinico-pathological prognostic factors including gender, age, histology, disease free interval, number or size of pulmonary metastatic tumors, and the operative procedure. Both age (older than 60 years) (P=0.0189) and pulmonary metastases from squamous cell carcinomas in either oral cavity or pharyngeal region (P=0.0002) were identified to be adverse prognostic factors. To obtain a long survival, a positive surgical resection is considered to be an effective and standard treatment for pulmonary metastasis from malignant head and neck tumor. It is also necessary, however, to elucidate fully the primary site and histology of such pulmonary metastasis.
2010 Published by European Association for Cardio-Thoracic Surgery. All rights reserved.
Similar articles
-
Pulmonary metastasectomy for pulmonary metastases of head and neck squamous cell carcinomas.Ann Thorac Surg. 2009 Sep;88(3):856-60. doi: 10.1016/j.athoracsur.2009.04.040. Ann Thorac Surg. 2009. PMID: 19699911
-
Does surgical resection of pulmonary metastases of head and neck cancer improve survival?Ann Surg Oncol. 2008 Oct;15(10):2915-26. doi: 10.1245/s10434-008-0001-4. Epub 2008 Jul 22. Ann Surg Oncol. 2008. PMID: 18648883
-
Prediction of prognosis and surgical indications for pulmonary metastasectomy from colorectal cancer.Ann Thorac Surg. 2006 Jul;82(1):254-60. doi: 10.1016/j.athoracsur.2006.02.027. Ann Thorac Surg. 2006. PMID: 16798225
-
Benefits of surgery for patients with pulmonary metastases from colorectal carcinoma.Ann Thorac Surg. 2004 Jul;78(1):238-44. doi: 10.1016/j.athoracsur.2004.02.017. Ann Thorac Surg. 2004. PMID: 15223436 Review.
-
Histopathologic prognostic factors in resected colorectal lung metastases.Ann Thorac Surg. 2005 Jan;79(1):278-82; discussion 283. doi: 10.1016/j.athoracsur.2004.06.096. Ann Thorac Surg. 2005. PMID: 15620957 Review.
Cited by
-
Survival Outcomes of Complete Pulmonary Metastasectomy for Head and Neck Squamous Cell Carcinomas.Cancer Manag Res. 2022 Oct 26;14:3095-3103. doi: 10.2147/CMAR.S383787. eCollection 2022. Cancer Manag Res. 2022. PMID: 36311682 Free PMC article.
-
Approach to the Patient with Recurrent/Metastatic Disease.Curr Treat Options Oncol. 2019 Jun 25;20(8):65. doi: 10.1007/s11864-019-0664-z. Curr Treat Options Oncol. 2019. PMID: 31240480 Review.
-
Approaches to the Management of Metastatic Adenoid Cystic Carcinoma.Cancers (Basel). 2022 Nov 20;14(22):5698. doi: 10.3390/cancers14225698. Cancers (Basel). 2022. PMID: 36428790 Free PMC article. Review.
-
Pulmonary metastasectomy: an overview.J Thorac Dis. 2017 Oct;9(Suppl 12):S1291-S1298. doi: 10.21037/jtd.2017.03.175. J Thorac Dis. 2017. PMID: 29119017 Free PMC article. Review.
-
Recurrent Versus Metastatic Head and Neck Cancer: An Evolving Landscape and the Role of Immunotherapy.Biomedicines. 2024 Sep 12;12(9):2080. doi: 10.3390/biomedicines12092080. Biomedicines. 2024. PMID: 39335592 Free PMC article. Review.
MeSH terms
LinkOut - more resources
Full Text Sources
Medical